Pharmacological Reviews
Brief Name:
PHARMACOL REV
Impact factor:
19.3 (2023)
ISSN:
0031-6997
Home Page:
Open Access:
No
Publisher:
American Society for Pharmacology and Experimental Therapeutics
Publication Frequency:
Quarterly
Article Processing Charge:
USD $3,500 for CC BY and $2,500 for CC BY-NC
Publication Start Year:
1949
Annual Articles:
36
Self-citation Rate:
0.2%
Chinese Academy of Sciences SCI Journal Classification:
| Major category | Ｍinor category | TOP journal | Ｒeview journal |
|---|---|---|---|
Q1 MEDICAL |
PHARMACEUTICALLY | Yes | Yes |
Subject Classification:
PHARMACOLOGY & PHARMACY
CiteScore:
| CiteScore | SJR | SNIP | CiteScore ranking | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 34.7 | 6.05 | 4.626 |
|
H-Index:
210
SCI Index Status:
Science Citation Index Expanded
PubMed Central:
Submission Site:
Aims and Scope:
Pharmacological Reviews is a peer-reviewed journal that presents important review articles covering the broad spectrum of pharmacological research. Topics covered have included biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology, clinical pharmacology, and toxicology. IUPHAR nonmenclature reports are published here.
Disclaimer:
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.